Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead will donate meds for US push to end HIV epidemic
Yahoo/AP
Thu, 05/9/19 - 11:39 pm
Tags:
Gilead Sciences, HIV, donations, Truvada
Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases
Marketwatch
Wed, 05/8/19 - 09:45 am
Tags:
Gilead Sciences, Goldfinch Bio, drug development, kidney disease
Where Will Gilead Sciences Spend Its Cash?
Motley Fool
Tue, 05/7/19 - 10:03 am
Tags:
Gilead Sciences, M&A, Atara, Exelixis
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
Motley Fool
Sun, 05/5/19 - 10:34 am
Tags:
Gilead Sciences, Daniel O'Day, M&A, Kite Pharma, filgotinib
Gilead's first move under new chief is to untether Kite
Biopharma Dive
Fri, 05/3/19 - 10:47 pm
Tags:
Kite Pharma, Gilead Sciences, CAR-T, Daniel O'Day
Has Gilead Sciences Turned the Corner?
Motley Fool
Fri, 05/3/19 - 10:24 am
Tags:
Gilead Sciences, earnings
Gilead stock ticks higher as earnings beat Street, revenue doesn't
Marketwatch
Thu, 05/2/19 - 08:05 pm
Tags:
Gilead Sciences, earnings
3 Things You Can Expect in Gilead Sciences' Q1 Earnings Update
Motley Fool
Wed, 05/1/19 - 10:53 am
Tags:
Gilead Sciences, earnings
2 Reasons Gilead Sciences' NASH Program Could Bounce Back
Motley Fool
Sun, 04/28/19 - 12:20 pm
Tags:
Gilead Sciences, NASH
How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life
Motley Fool
Sat, 04/27/19 - 10:47 am
Tags:
Gilead Sciences, Novartis, CMS, Medicare, CAR-T
Gilead's selonsertib fails PhIII in less sick NASH patients — to no one's surprise
Endpoints
Thu, 04/25/19 - 10:35 am
Tags:
Gilead Sciences, NASH, clinical trials, selonsertib
Department of Justice Reviewing Gilead and CDC’s HIV Patents
BioSpace
Thu, 04/25/19 - 10:34 am
Tags:
DOJ, patents, Gilead Sciences, CDC, HIV, Truvada
Kite's CAR-T manufacturing gets another boost with new Maryland facility
Fierce Pharma
Wed, 04/24/19 - 04:07 pm
Tags:
Gilead Sciences, Kite Pharma, drug manufacturing, Maryland, CAR-T
What’s it take to recruit a top drug development exec out of Gilead? Stock options help, a lot
Endpoints
Tue, 04/23/19 - 11:03 pm
Tags:
biotech, stock options, executive pay, Gilead Sciences
HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey
Fierce Pharma
Thu, 04/18/19 - 11:07 am
Tags:
reputation, Gilead Sciences, ViiV
Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO
Endpoints
Thu, 04/18/19 - 10:13 am
Tags:
Hookipa, Gilead Sciences, IPOs
In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead
Stat
Tue, 04/16/19 - 10:42 am
Tags:
artificial intelligence, machine learning, drug discovery, Insitro, Gilead Sciences
Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs
TheStreet.com
Fri, 04/12/19 - 10:05 am
Tags:
NASH, Gilead Sciences, Novo Nordisk, clinical trials
Gilead shores up hope for NASH cocktail with a glimpse at positive proof-of-concept data
Endpoints
Thu, 04/11/19 - 12:33 pm
Tags:
Gilead Sciences, NASH, cilofexor, firsocostat, selonsertib
Gilead cuts cardiopulmonary sales reps
BioCentury
Wed, 04/10/19 - 11:44 pm
Tags:
Gilead Sciences, layoffs, generics, Letairis, Ranexa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.